The purpose of the study is to provide use of Omegaven in children with life threatening
Total Parenteral Nutrition (TPN) associated cholestasis when all other medical and surgical
treatments/therapies have been either ineffective or not feasible in the treatment of this
serious condition. This is a compassionate use protocol.